Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO® ...Middle East

STOCKHOLM, June 21, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced the submission of a supplemental New Drug Application ("sNDA") to the U.S. Food and Drug Administration ("FDA") seeking full approval of TARPEYO®...

Hence then, the article about calliditas therapeutics submits supplemental new drug application to u s food and drug administration for full approval of tarpeyo was published today ( Wednesday 21/06/2023 - 11:13 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO® )

Also on site :

• Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
• Iranians Fear Trump’s Threat to Strike Power Plants
• Crimson Desert patch 1.00.03 addresses storage issues, Keyboard & mouse controls & more